C1QL3

Chr 10

complement C1q like 3

Also known as: C1QTNF13, C1ql, CTRP13, K100

Predicted to enable identical protein binding activity. Predicted to be involved in maintenance of synapse structure and trans-synaptic signaling, modulating synaptic transmission. Predicted to act upstream of or within regulation of synapse organization. Predicted to be located in extracellular region. Predicted to be active in obsolete extracellular space; synapse; and synaptic cleft. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
6
Pubs (1 yr)
P/LP submissions
P/LP missense
0.76
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.76LOEUF
pLI 0.516
Z-score 1.94
OE 0.16 (0.060.76)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint?
2.12Z-score
OE missense 0.49 (0.400.60)
65 obs / 133.9 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.16 (0.060.76)
00.351.4
Missense OE?0.49 (0.400.60)
00.61.4
Synonymous OE?0.89
01.21.6
LoF obs/exp: 1 / 6.2Missense obs/exp: 65 / 133.9Syn Z: 0.69

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

C1QL3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →